O

Option Care Health

Largest independent home infusion therapy provider

Warehouse Pharmacy Technician

Full-TimeUpdated on 10/23/2026
$16.61 - $26.96+ 401(k) Match
Entry
Associate's
Savannah, GA, USA
In Person
Medical, Clinical & VeterinaryPharmacy

About the job

Requirements
  • A high school diploma or equivalent is required.
  • A valid driver’s license, a driving record meeting company standards, and current auto insurance are required.
  • Must meet applicable state requirements for pharmacy technician registration, licensure, or certification.
  • In Texas, Pharmacy Technician in Training status is required; Registered Pharmacy Technician status is preferred.
  • In Ohio, pharmacy technicians must be registered and may not perform duties related to sterile compounding.
  • Remain aware of the supervisory pharmacist’s responsibility for medication integrity during preparation, storage, and shipping.
  • Know the geography served by the Pharmacy, including traffic patterns and drive times.
  • Understand all service options and delivery-time commitments.
  • Know accreditation standards and requirements.
  • Read, analyze, and interpret operational logistics functions relevant to assigned duties; operate information systems; follow policy; complete required forms; and prepare reports.
  • Perform basic mathematical calculations.
  • Identify problems, collect data, establish facts, and contribute to valid conclusions.
Responsibilities
  • Develop a positive working rapport with courier services where applicable and understand their response times, delivery protocols, after-hours service, and compliance with federal, state, and local regulations, as well as HIPAA and ACHC requirements.
  • When applicable, maintain the assigned vehicle in a clean and orderly condition, report mechanical problems to a supervisor, and develop an alternate delivery plan for emergency breakdowns.
  • Gather and check compounding materials before they enter the clean room.
  • Compound sterile preparations as needed.
  • Check final products for particulate matter and container integrity before presenting them to a pharmacist for final review.
  • Label compounded sterile preparations when permitted by state regulations.
  • Check ancillary supplies.
  • Pick and pack supplies.
  • Develop efficient territory-management and delivery zones; coordinate with customer service and Pharmacy to process delivery tickets and compounding documents on time; ensure cost-effective delivery methods; track delivery-ticket lead times; and coordinate with Pharmacy Technicians to prioritize the mixing schedule and meet delivery commitments.
  • Use delivery and warehouse best practices, maintain a safe work environment, and track delivery costs.
  • Assist in orienting new warehouse team members.
  • Participate in the inventory count process through final reporting.
  • Maintain the warehouse safely.
  • Facilitate efficient workflow and inventory stocking.
  • Assemble and prepare patient deliveries.
  • Receive and stock incoming orders.
  • Perform routine maintenance, testing, and cleaning of returned equipment.
  • Control product inventory, rotate stock as needed, and promptly notify appropriate personnel of shortages.
  • Accurately compile ordered medication, supplies, equipment, and associated documentation for delivery, and obtain supervisory cross-checking of order accuracy.
  • Follow company performance programs, policies, procedures, guidelines, and internal-control standards applicable to the role, and understand internal-control procedures communicated by the manager.
  • Report concerns about internal-control deficiencies.
  • Perform other duties as assigned.
Desired Qualifications
  • An associate’s degree is preferred.
  • One year of experience in warehouse, distribution, or inventory work and healthcare is preferred.

About the company

Option Care Health delivers infusion therapies at home and other alternate-site locations across the United States, supported by over 7,000 teammates including about 4,500 clinicians. Clinicians visit patients at home or approved sites to administer therapies, manage care, and coordinate with care teams under strong clinical leadership and national scale. It stands out as the largest independent infusion provider with nationwide reach and a robust clinical workforce, enabling scalable home and alternate-site infusion rather than hospital-only care. The goal is to elevate standards of care and reimagine the infusion care experience by expanding access, improving outcomes, and delivering compassionate, clinically driven service.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Bannockburn, Illinois

Founded

1979

Get referred to Option Care Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 29, 2026 Q2 revenue reached $1.44 billion, while acute therapy and IG Neuro strengthened.
  • Management stabilized CID patient census in Q2 2026 and kept full-year revenue guidance unchanged.
  • The company repurchased $150 million in Q2 2026, signaling confidence and shareholder-return capacity.

What critics are saying

  • August 2026 guidance still bakes in a 600-basis-point CID revenue headwind and $55 million gross profit hit.
  • July 29, 2026 Q2 buyback of $150 million masks weak top-line momentum and analyst skepticism.
  • Biosimilar erosion and payer reverification pressure can permanently shrink chronic volumes if retention stays broken.

What makes Option Care Health unique

  • Option Care Health leads U.S. independent home and alternate-site infusion, with nationwide clinician density.
  • Its payer, biopharma, and prescriber relationships create switching costs across chronic and acute therapies.
  • August 27, 2026 guidance shows durable cash generation, with at least $320 million operating cash flow.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Paid Time Off
  • Bonding Time Off
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Health Savings Account/Flexible Spending Account
  • Flexible Spending Accounts
  • Tuition Reimbursement
  • Family Support
  • Mental Health Support

Company News

AD HOC NEWS
Oct 15th, 2026
McKesson commits $1.4B for 49% stake in Option Care at $5.8B valuation

McKesson will invest $1.4 billion for a 49% minority stake in Option Care Health, under an agreement announced on October 6, 2026. The deal values Option Care at an enterprise value of $5.8 billion. Clayton, Dubilier & Rice will hold about 51%. Option Care will stay separately managed, while McKesson keeps a framework to acquire the remaining interest later, subject to conditions and regulatory approvals. In its first fiscal 2027 quarter, McKesson reported revenue of $105.38 billion, up 7.7% year on year, and adjusted earnings per share of $9.93. It will report second-quarter results on November 4, 2026.

Yahoo Finance
Oct 6th, 2026
McKesson and Clayton Dubilier & Rice near $5B deal to acquire Option Care Health

Option Care Health shares jumped 33.2% in pre-market trading after the Financial Times reported McKesson and Clayton Dubilier & Rice are nearing a transaction valued at over $5 billion to acquire the alternate site health provider. According to the report, the deal would involve the two firms partnering to buy the infusion services provider, which they view as undervalued. Large-scale buyout discussions typically drive market optimism as investors anticipate acquisition premiums. The move is significant for Option Care Health, whose shares have experienced 13 movements greater than 5% over the past year. At $31.03 per share, the stock is trading 15.2% below its 52-week high but remains down 3.8% year-to-date.

Central Charts
Oct 6th, 2026
CD&R and McKesson Corporation Sign Agreement to Acquire Option Care Health

CD&R, McKesson Corporation (NYSE: MCK) (“McKesson”), and Option Care Health, Inc. (Nasdaq: OPCH) (“Option Care Health”) announced today that they have

Yahoo Finance
Jul 29th, 2026
Option Care Health Q2 beats expectations with $1.4B revenue, narrows full-year guidance

Option Care Health reported second-quarter 2026 results that exceeded expectations. Revenue rose 7% sequentially to $1.4 billion, whilst adjusted EBITDA increased 12% to $117.5 million and adjusted EPS reached $0.45. Operating cash flow totalled $184 million. Acute therapies posted high-single-digit organic growth, while chronic revenue improved sequentially as the CID portfolio began to stabilise. However, CID-related pressure is expected to reduce 2026 revenue by roughly 600 basis points and gross profit by $55 million. The home and alternate-site infusion provider maintained its full-year revenue guidance at $5.675 billion to $5.775 billion. Adjusted EBITDA guidance was narrowed to $480 million to $495 million, and adjusted EPS guidance to $1.85 to $1.92. The company repurchased $150 million of shares, nearly 5% of shares outstanding.

Yahoo Finance
Jul 29th, 2026
Option Care Health reports $1.44B Q2 revenue, up 1.9%, and raises $150M share buyback

Option Care Health, the largest independent provider of home and alternate site infusion services in the US, reported second quarter 2026 results. Net revenue reached $1.44 billion, up 1.9% year-over-year. The company posted net income of $53.9 million, up 6.7%, with diluted earnings per share of $0.35, up 12.9%. Adjusted EBITDA grew 3.0% to $117.5 million. The company repurchased $150 million of outstanding shares during the quarter. For full year 2026, Option Care Health expects net revenue between $5.68 billion and $5.78 billion, with adjusted diluted earnings per share of $1.85 to $1.92. The company forecasts adjusted EBITDA of $480 million to $495 million and operating cash flow of at least $320 million.